GenVec Inc. Announces $1.7 Million Collaboration For Continued Development Of A Foot And Mouth Disease Vaccine Foot And Mouth Disease Vaccine

2006-03-01

疫苗

GAITHERSBURG, Md.--(BUSINESS WIRE)--March 1, 2006--GenVec, Inc. (Nasdaq:GNVC) announced today that it has received an additional $1.7 million in support provided by the U.S. Department of Agriculture (USDA)-Agricultural Research Service (ARS) funded through an interagency agreement by the U.S. Department of Homeland Security (DHS) Science and Technology Directorate to advance the development of countermeasure vaccines to prevent the spread of foot-and-mouth disease (FMD). FMD has been identified as a key potential threat to the U.S. economy and the country's food supply, whether infection were to occur as a result of bioterrorism or by accidental exposure to the disease. GenVec is developing candidate vaccines and anti-viral agents to prevent the spread of FMD through a multi-year research collaboration with the ARS and will use the additional DHS funding to support the company's activities this year.

机构